C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
ACB Canadian LP

Aurora Cannabis

NYSE · ACB

Canadian LP with medical and recreational operations in Canada and international medical cannabis markets.

$2.79
-1.41%
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 2/5
56/100 composite
Fundamentals57
Regulatory88
Market40
Editorial30
Composite · trailing 12 months

The model outputs a Neutral rating for Aurora Cannabis, scoring 56/100 at conviction 2 of 5. Weights are locked at 35 percent fundamentals, 25 percent regulatory, 25 percent market, and 15 percent editorial, and each pillar is broken out for direct review. The regulatory pillar contributes the largest share at 88, pulling the composite into the middle of the band. Opposite that, editorial prints only 30, and is what keeps the rating anchored where it is.

Pillar-level, the record reads as reported revenue growth of 5.1 percent year over year, an operating margin of -26.4 percent, a filing cadence of 8 regulator events in the trailing 90 days. Each of those data points tethers the Neutral conclusion to observable evidence. Inputs are limited to primary regulatory filings, licensed fundamentals data, and institutional pricing feeds, plus a density read from CIN newsroom coverage. The rating enables direct comparison across the 336 tickers in the CIN coverage universe on a consistent, deterministic basis, and refreshes on a scheduled cadence tied to the primary-source ingest cycle.

Watch the regulatory pillar, which drives 88 of the composite. Continued filing cadence at or above the trailing 90-day pace, matched with a clean enforcement record, would justify moving toward the upper band edge.

Scored: 2026-07-14Valid through: 2026-08-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
Corporate DetailsCompany profile
Headquarters
2207 90B STREET SW, EDMONTON, A0, T6X 1V8
Phone
604-362-5207
CEO
Miguel Ma***n
CFO
Simona Ki***g
SEC CIK
1683541
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$167.9M
Enterprise value
$102.9M
Price to book
0.46
Price to sales
0.52
EV / EBITDA
15.32
Revenue (TTM)
$320.6M
Gross profit (TTM)
$136.7M
EBITDA
$-33.0M
Operating margin
-26.4%
Profit margin
-42.4%
Rev growth YoY
5.1%
Return on equity
-10.5%
Return on assets
-4.0%
EPS (TTM)
$-0.73
EPS est. current year
$-0.01
Wall St. target price
$6.23
Shares outstanding
61.9M
Insider ownership
1.3%
Institutional ownership
9.7%
Beta
1.35
Full-time employees
1,028
GICS sector
Healthcare
GICS industry
Drug Manufacturers - Specialty & Generic
Filings & DisclosuresPrimary sources
Filing portal
SEDAR+
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for Aurora Cannabis (ACB)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Aurora Cannabis (ACB), a cannabis-sector equity listed on NYSE in the Canadian LP category. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Avoid / Capital Risk. Multiple flags: deep drawdown. (0 bullish signals, 3 bearish signals.)

Canadian LP with medical and recreational operations in Canada and international medical cannabis markets.

Latest price: $2.79 (-1.41%) on NYSE.

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for ACB are maintained by Cannabis Investor News and refreshed throughout the trading day.